- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Emerald Health Therapeutics Gets Approval for New Organic Facility
Emerald Health Therapeutics secured a cultivation license for an organic cannabis facility in Vancouver, BC.
Emerald Health Therapeutics (TSXV:EMH,OTCQX:EMHTF) secured a cultivation license for an organic cannabis facility in Vancouver, BC.
As quoted in the press release:
Emerald Health Therapeutics has received its initial cultivation license from Health Canada for its new organic cannabis growing facility in Metro Vancouver, BC. Tailor-made for Emerald to produce high-quality organic cannabis, the operation comprises two 78,000 square foot greenhouses and 12 acres (~500,000 square feet) of outdoor cultivation, with potential for an additional 12 acres. This license permits cultivation in an initial 15,000 square feet of greenhouse area. This site was purposefully designed for organic cultivation with the goal to exceed 30,000 kilograms of annual production, assuming licensing of the entire indoor and outdoor production area.
“Organic products appeal to many consumers, including many cannabis users, and we look forward to serving both medical and recreational consumers with our quality organic cannabis products,” said Dr. Avtar Dhillon, Executive Chairman and President of Emerald.
Construction of the first greenhouse is complete; the second greenhouse is expected to be completed in Q4; and the first 12 acres of outdoor area is ready for planting. Production at the facility is subject to obtaining necessary municipal approvals, which Emerald is working to complete.
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.